Pharmaceuticals - Community Register


List of refusals for human medicinal products


Product name: Movectro
Active substance: Cladribine
Indication: MOVECTRO is indicated as a single disease modifying therapy in highly active relapsing-remitting multiple sclerosis (MS)
Marketing Authorisation Holder: Merck Serono Europe Limited

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/06/2011 Centralised - Refusal of marketing authorisation EMEA/H/C/1197 (2011)4471 of 17/06/2011
26/08/2011 Corrigendum (2011)4471 cor of 17/06/2011